Tianxi Cai, ScD
Professor of Biomedical Informatics, Harvard Medical School
John Rock Professor of Population and Translational Data Sciences, Harvard T.H. Chan School of Public Health
Director, Translational Data Science Center for a Learning Health System (CELEHS)
Tianxi Cai is a major player in developing analytical tools for mining EHR data and predictive modeling with biomedical data. She provides statistical leadership on several large-scale projects, including the NIH-funded Undiagnosed Diseases Network at DBMI. Cai's research lab develops novel statistical and machine learning methods for several areas including clinical trials, real world evidence, and personalized medicine using genomic and phenomic data. Cai received her ScD in Biostatistics at Harvard and was an assistant professor at the University of Washington before returning to Harvard as a faculty member in 2002.
DBMI Research Areas
Robust approach to combining multiple markers to improve surrogacy.
Binary acronym disambiguation in clinical notes from electronic health records with an application in computational phenotyping.
Authors: Link NB, Huang S, Cai T, Sun J, Dahal K, Costa L, Cho K, Liao K, Cai T, Hong C.
Int J Med Inform
View full abstract on Pubmed
Int J Med Inform
View full abstract on Pubmed
Longitudinal imaging history in early identification of intimate partner violence.
Authors: Park H, Gujrathi R, Gosangi B, Thomas R, Cai T, Chen I, Bay C, Hassan N, Boland G, Kohane I, Seltzer S, Rexrode K, Khurana B.
Eur Radiol
View full abstract on Pubmed
Eur Radiol
View full abstract on Pubmed
Geometric Features Associated with Middle Cerebral Artery Bifurcation Aneurysm Formation: A Matched Case-Control Study.
Authors: Zhang J, Can A, Lai PMR, Mukundan S, Castro VM, Dligach D, Finan S, Gainer VS, Shadick NA, Savova G, Murphy SN, Cai T, Weiss ST, Du R.
J Stroke Cerebrovasc Dis
View full abstract on Pubmed
J Stroke Cerebrovasc Dis
View full abstract on Pubmed
Semisupervised Calibration of Risk with Noisy Event Times (SCORNET) using electronic health record data.
Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.
Risk of Infections With Ustekinumab and Tofacitinib Compared to Tumor Necrosis Factor a Antagonists in Inflammatory Bowel Diseases.
Authors: Cheng D, Kochar BD, Cai T, Ananthakrishnan AN.
Clin Gastroenterol Hepatol
View full abstract on Pubmed
Clin Gastroenterol Hepatol
View full abstract on Pubmed
Temporal trends of multiple sclerosis disease activity: Electronic health records indicators.
Authors: Liang L, Kim N, Hou J, Cai T, Dahal K, Lin C, Finan S, Savovoa G, Rosso M, Polgar-Tucsanyi M, Weiner H, Chitnis T, Cai T, Xia Z.
Mult Scler Relat Disord
View full abstract on Pubmed
Mult Scler Relat Disord
View full abstract on Pubmed
Individual Data Protected Integrative Regression Analysis of High-Dimensional Heterogeneous Data.
Testing for heterogeneity in the utility of a surrogate marker.